Business Context and Reporting Period
This Form 8-K was filed by pSivida Corp. (noted as Eyepoint, Inc. in metadata) on January 18, 2011. The report details a private placement offering of common stock and warrants to institutional investors. The transaction utilizes a shelf registration statement (Form S-3) that became effective on January 7, 2010.
Key Financial Metrics
- Gross Proceeds: Approximately $10.75 million.
- Net Proceeds: Approximately $9.9 million (after deducting placement agent fees and estimated offering expenses).
- Shares Offered: 2,150,000 shares of common stock.
- Warrants Issued: Warrants to purchase 537,500 shares of common stock (25% of shares purchased).
- Warrant Terms: Exercise price of $5.00 per share; exercisable for five years from the issuance date.
Material Changes
The filing reports the entry into placement agent agreements with Rodman & Renshaw, LLC (lead agent) and Ladenburg Thalmann & Co. Inc. (co-agent). This represents a significant capital raise event. The filing text does not provide comparative financial data (revenue, profit, or margins) against prior periods as this is a current event report rather than a periodic financial statement.
Outlook, Risks, and Unusual Items
Closing Date: The offering is expected to close on or about January 24, 2011, subject to customary closing conditions.
Management Commentary: A press release announcing the pricing of the offering was issued on January 19, 2011.
Risks/Contingencies: The closing is contingent upon customary conditions. The offering is made pursuant to a prospectus supplement filed with the SEC.
Investor Verification Checklist
- Verify the final closing date of the offering (expected January 24, 2011).
- Confirm the actual net proceeds received after finalizing all offering expenses.
- Review the attached Securities Purchase Agreement (Exhibit 99.4) for specific investor rights and covenants.
- Check the press release (Exhibit 99.6) for any additional details on the use of proceeds or strategic implications.